IP Library Granted Patent US 7,919,592
Granted Patent B2
US 7,919,592 · App. 10/386,486 · Granted Apr 5, 2011

Method for separating off viruses from a protein solution by means of nanofiltration

Assignee: ZLB Behring GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,919,592
App. No.
10/386,486
Granted
Apr 5, 2011
Kind
B2
Abstract

A method for separating off viruses from a protein solution by nanofiltration, comprising adding to the protein solution at least one ingredient chosen from chaotropic substances chosen from arginine, guanidine, citrulline, urea and derivatives thereof and salts thereof, and compounds chosen from polyethoxysorbitan esters and derivatives thereof, prior to the nanofiltration, in order to decrease or prevent aggregation of the protein molecules, and then filtering the solution through a filter having a pore size ranging from 15 nm to less than 35 nm.

Claims (5)

1. A method for separating off viruses from a protein solution by nanofiltration, comprising adding to the protein solution at least one ingredient chosen from chaotropic substances chosen from arginine, guanidine, citrulline, urea and derivatives thereof and salts thereof, and then filtering the protein solution through a filter having a pore size ranging from 15 nm to less than 35 nm, wherein the protein solution is a fibrinogen solution, wherein the pore size is less than the single particle size of the viruses, and wherein the fibrinogen passes through the filter and the filter retains the viruses.

2. The method according to claim 1 , wherein said method is carried out at room temperature.

3. The method according to claim 1 , further comprising a pasteurization.

4. The method according to claim 1 , wherein the filter has a pore size ranging from 15 nm to 25 nm.

5. The method according to claim 1 , wherein the chaotropic substance is arginine or a salt thereof.

Assignments (2)
CHANGE OF NAME Recorded Nov 15, 2004
From: AVENTIS BEHRING GMBH
To: ZLB BEHRING GMBH
Reel/Frame 015376/0009 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2003
From: LENGSFELD, THOMAS; SCHNEIDER, HEINRICH
To: AVENTIS BEHRING GMBH
Reel/Frame 014244/0727 →
Priority Claims (1)
DE 102 11 632 · Mar 15, 2002 · national
Continuity (1)
Related Publication 20030232969A1 · Dec 18, 2003